RE: SimplyWallet - 1st July Update (except Spreadex)12 Sep 2020 18:38
Hi Dave,
Now that's a question ! LOL
I posted the following a while back, and not everyone agreed, but I still stand by it:
Ok, we may not sell all Tests to the USA for £10/Test, but we may well sell more than 50,000 per day, especially when considering sells to India; Africa etc, etc:
I believe that GDR Mcap is potentially worth £300 mil Mcap, based on projected Sales and Profit.
I expect GDR to sell 50,000 RT-PCR Test units/day at £10 per Test = £500,000 per day revenue at 60% profit margin = £300,000 per day profit.
Working on a 5 day week = 5 x £300,000 = £1,500,000 profit per week.
£1,500,000 x 50 wks per year = £75,000,000 profit per year.
Using a standard multiple of 4 for valuation = 4 x £75,000,000 = Mcap of £300,000,000
Mcap of £300,000,000 divided by 52,000,000 shares = a potential SP of £5.77p
This Mcap valuation did not take into consideration a valuation of our POC; HCV OR AIHL etc
So in answer to your question - we would reject any bid under £6 per GDR share !